Coinjection of anti-interleukin-2 receptor antibody diminishes antiantibody formation during prolonged treatment with anti-CD3 antibody.
Mysliwietz
J
J
Institut für Immunologie der GSF, Forschungszentrum für Umwelt und Gesundheit, Munich, Germany.
Thierfelder
S
S
D000818:Animals; D000888:Antibodies, Anti-Idiotypic / Q000096:biosynthesis* / Q000097:blood; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000494:pharmacology; D017252:CD3 Complex / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D051381:Rats; D015375:Receptors, Interleukin-2 / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D015375:Receptors, Interleukin-2